Stay updated on Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:47:17.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the enrollment number for the phase II trial studying the effectiveness of nivolumab and ipilimumab in treating patients with hormone-resistant prostate cancer expressing AR-V7. This change reflects an update in the study's enrollment status related to medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:50.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    54%
    Check dated 2024-05-22T20:59:54.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:21:35.000Z thumbnail image

Stay in the know with updates to Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.